In the mid- 80’s, with the aim to be become a global player, beyond national borders, we engaged in the fascinating part of our industry, that of research and development. We entered into a niche market where big pharma showed no interest, that of pharmaceutical technology. We thus established our first in-house Research & Development unit in Greece, focusing mainly on novel forms of drug delivery systems.
We welcomed the 90s by expanding our research activities beyond Greece. We invested abroad, establishing a strong research team in New Jersey, the heart of pharmaceutical technology in the USA.
In the beginning of the new millennium, we inaugurated a new research facility near Princeton University in New Jersey – a strategic and advantageous location allowing us to have direct access to the most distinguished scientists and the largest pharmaceutical companies in the world.
Nowadays, equipped with experience, know-how and valuable expertise, we are focused on the research and development of transdermal drug delivery systems, an area where we aspire to be one of the most important players worldwide.